Gene transfer of angiostatin inhibited tumor angiogenesis and enhanced NK cell infiltration, while B7H3 therapy activated CD8+ and NK cells and increased their infiltration into the tumor, and enhanced circulating IFN-γ levels. Here, CD276 is linked to neoplasm.